Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,701–1,800 of 2,883
Treating Senescence like Cancer: Novel Perspectives in Senotherapy of Chronic Diseases
Mongelli, A., Atlante, S., Barbi, V., Bachetti, T., Martelli, F., Farsetti, A., & Gaetano, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217984 · Cited by 13
Making headlines: an analysis of US government-funded cancer research mentioned in online media
Maggio, L. A., Ratcliff, C. L., Krakow, M., Moorhead, L. L., Enkhbayar, A., & Alperín, J. P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025783 · Cited by 12
Navitoclax improves acute‐on‐chronic liver failure by eliminating senescent cells in mice
Watanabe, Y., Abé, H., Kimura, N., Arao, Y., Ishikawa, N., Yuichiro, M., Setsu, T., Sakamaki, A., Kamimura, H., Yokoo, T., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13879 · Cited by 14
“Thus, cellular senescence has a negative effect on the liver and may be the ACLF etiology.(24,25)”
BackgroundWang, N., Fang, Y., Hou, Y., Cheng, D., Dressler, E. V. M., Wang, H., Wang, J., Wang, G., Li, Y., Liu, H., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01861-x · Cited by 22
Lysosomes and Their Role in Regulating the Metabolism of Hematopoietic Stem Cells
Arif, T. (2022) · Biology · doi:10.3390/biology11101410 · Cited by 13
PAI-1 is a common driver of aging and diverse diseases
Khoddam, A., Miyata, T., & Vaughan, D. E. (2025) · Biomedical Journal · doi:10.1016/j.bj.2025.100892 · Cited by 18
“Research has shown that interventions targeting senescent cells can extend lifespan of murine models [29 – 31].”
Anerillas, C., Altés, G., Gresova, K., Tsitsipatis, D., Mazan-Mamczarz, K., Banarjee, R., Cunningham, A. S. G., Salamini-Montemurri, M., Yang, J.-H., Munk, R., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.05.017 · Cited by 11
Park, S. S., Lee, Y., Kim, Y. H., Park, S. H., Kang, H. Y., Kim, J. C., Kim, D. J., Lim, S. B., Yoon, G., Kim, J., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01354-4 · Cited by 18
Myogenic marker expression as a function of age and exercise-based therapy in the tongue
Kletzien, H., Kelm‐Nelson, C. A., Wang, S. M., Suzuki, M., & Connor, N. P. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111104 · Cited by 13
Single cell analysis of senescent epithelia reveals targetable mechanisms promoting fibrosis
(2022) · doi:10.1101/2022.03.21.485189 · Cited by 43
Id1 expression in kidney endothelial cells protects against diabetes‐induced microvascular injury
Sharma, S. G., & Plotkin, M. D. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12793 · Cited by 11
En, A., Watanabe, K., Ayusawa, D., & Fujii, M. (2022) · FEBS Journal · doi:10.1111/febs.16584 · Cited by 11
Exploring replication stress and cellular senescence as key targets in novel cancer therapies
Ray, S. K., & Mukherjee, S. (2025) · Cancer Genetics · doi:10.1016/j.cancergen.2025.09.002 · Cited by 15
Bmal1-deficient mouse fibroblast cells do not provide premature cellular senescence in vitro
Nakahata, Y., Yasukawa, S., Khaidizar, F. D., Shimba, S., Matsui, T., & Bessho, Y. (2018) · Chronobiology International · doi:10.1080/07420528.2018.1430038 · Cited by 14
Rothmiller, S., Jäger, N., Meier, N., Meyer, T., Neu, A., Steinritz, D., Thiermann, H., Scherer, M. A., Rummel, C., Mangerich, A., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02946-5 · Cited by 13
Page, M. M., Schuster, E. F., Mudaliar, M., Herzyk, P., Withers, D. J., & Selman, C. (2018) · Aging · doi:10.18632/aging.101446 · Cited by 11
Cellular senescence and developmental defects
Klein, A., Rhinn, M., & Keyes, W. M. (2023) · FEBS Journal · doi:10.1111/febs.16731 · Cited by 14
Mao, X., Li, L., Lee, G., Agborbesong, E., Zhou, J. X., Calvet, J. P., & Li, X. (2025) · Kidney International · doi:10.1016/j.kint.2025.05.027 · Cited by 14
An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs
Bencivenga, D., Stampone, E., Vastante, A., Barahmeh, M., Ragione, F. D., & Borriello, A. (2022) · Cells · doi:10.3390/cells11081346 · Cited by 12
Sex, senescence, senolytics, and cognition
Foster, T. C., & Kumar, A. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1555872 · Cited by 16
“Removal of p16-expressing cells, starting in middle age, reduced the age-related increase in fat accumulation and increased spontaneous activity and exploratory behavior in both sexes (Baker et al., 2016).”
Yeh, C. (2016) · Oral Diseases · doi:10.1111/odi.12483 · Cited by 11
Sugiyama, Y., Harada, T., Kamei, Y., Yasuda, T., Mashimo, T., Nishikimi, A., & Maruyama, M. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112130 · Cited by 12
Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission
Liao, K.-M., Chen, C., Luo, W., Hsu, C.-W., Yu, S., Yang, P., & Su, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114616 · Cited by 11
Venz, R., Goyala, A., Soto-Gamez, A., Yenice, T., Demaria, M., & Ewald, C. Y. (2023) · GeroScience · doi:10.1007/s11357-023-00909-z · Cited by 14
Sharma, R., Kumar, R., Sharma, A., Goel, A., & Padwad, Y. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.01.425058 · Cited by 11
The African turquoise killifish Nothobranchius furzeri as a model for aging research
Reuter, H., Krug, J., Singer, P., & Englert, C. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2018.12.001 · Cited by 12
Liu, J., Yang, L., Wang, X., Wang, S., Huang, Z., Li, C., Liu, Y., Cheng, Y., Liu, C., & Wang, Z. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01923-0 · Cited by 11
Das, M., & Kale, V. P. (2021) · Cell Biology International · doi:10.1002/cbin.11691 · Cited by 11
Thermodynamics and Inflammation: Insights into Quantum Biology and Ageing
Nunn, A. V. W., Guy, G. W., & Bell, J. D. (2022) · Quantum Reports · doi:10.3390/quantum4010005 · Cited by 14
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights
Jain, A., Casanova, D., Padilla, A. V., Paniagua-Bojorges, A., Kotla, S., Ko, K. A., Samanthapudi, V. S. K., Chau, K. M., Nguyen, M. T., Wen, J. J., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1212174 · Cited by 13
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
Garana, B. B., Joly, J. H., Delfarah, A., Hong, H., & Graham, N. A. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05343-8 · Cited by 12
Purinergic signaling promotes premature senescence
Volonté, D., Benson, C. J., Daugherty, S. L., Beckel, J. M., Trebak, M., & Galbiati, F. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107145 · Cited by 17
“Senescent cells accumulate in tissues over time and contribute to both aging and the development of age-associated diseases (21 – 27).”
BackgroundZhou, L., DeMarco, K. D., Murphy, K. C., Wu, Z., Li, J., Johnson, C., Liu, B., Giwa, H. K., Ma, B., Bhalerao, N., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-1212 · Cited by 22
Okamura, K., Suzuki, T., & Nohara, K. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115259 · Cited by 11
Okudaira, N., Akimoto, M., Susa, T., Akimoto, M., Hisaki, H., Iizuka, M., Okinaga, H., Almunia, J. A., Ogiso, N., Okazaki, T., et al. (2024) · Aging Cell · doi:10.1111/acel.14206 · Cited by 12
“Therapeutics that target senescent cells may prevent aging comorbidities by targeting a fundamental aging mechanism (Baker et al., 2016); (Johmura et al., 2021); (Ogrodnik et al., 2019).”
Lack of a p16/ARF locus in fish genome may underlie senescence resistance in the fish cell line, EPC
Futami, K., Sato, S., Maita, M., & Katagiri, T. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104420 · Cited by 11
New Insights into Chronological Mobility of Retrotransposons In Vivo
Ghanam, A. R., Cao, J., Ouyang, X., & Song, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2818415 · Cited by 10
Hayashi, Y., Kawamura, R., Nishimatsu, S., Fukuta, O., & Nakashima, M. (2018) · Rejuvenation Research · doi:10.1089/rej.2018.2064 · Cited by 11
Fujiwara, Y., Ding, C., Sanada, Y., Yimiti, D., Ishikawa, M., Nakasa, T., Kamei, N., Imaizumi, K., Lotz, M., Akimoto, T., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1043259 · Cited by 12
“Aging and age-related diseases have been characterized by the accumulation of senescent cells in various tissues including cartilage and are associated with age-related pathogenesis (Baker et al., 2016; Farr et al., 2017; Jeon et al., 2017).”
BackgroundBlunting senescence boosts liver regenerationPreprint
Birch, J., & Gil, J. (2020) · Genes & Development · doi:10.1101/gad.337394.120 · Cited by 11
Kimura, M., Suzuki, S., Moriya, A., Nogami, K., Uchida, R., Saito, Y., & Saito, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010264 · Cited by 11
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
“…cells in both progeroid and naturally aged mice delays multiple aging phenotypes, including frailty, sarcopenia, cataract formation, cardiovascular dysfunction, and loss of hematopoietic regenerative capacity, while improving overall physiological function and extending lifespan 220,221 .”
Commentary on Some Recent Theses Relevant to Combating Aging: April 2016
Zealley, B., & de Grey, A. D. N. J. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1822 · Cited by 11
Wang, X., Guo, D. H., He, C., Wang, X., Yi, W., Zhang, F., Wang, L., & Yang, Y. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04360-z · Cited by 14
“Chronic immune activation may precipitate premature, age-independent immunosenescence, thereby heightening vulnerability to disease and exacerbating morbidity and mortality among the elderly population [21, 22].”
The role of RNA helicases in aging and lifespan regulation
Park, S., Park, H. H., Son, H. G., & Lee, S. (2017) · Translational Medicine of Aging · doi:10.1016/j.tma.2017.08.001 · Cited by 12
Fu, M., Zhang, Y., Peng, B., Luo, N., Zhang, Y., Zhu, W., Yang, F. J., Chen, Z., Zhang, Q., Li, Q., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179530 · Cited by 13
“Recent evidence suggests that ionizing radiation–induced senescence greatly impairs immune cell functions in mice (70), whereas elimination of senescent cells restores immune homeostasis within the tumor microenvironment and increases mouse survival in response to immunotherapy (71).”
Baker, J. R., Daly, L., Hassibi, S., Kimura, G., Nishimoto, Y., Kizawa, Y., & Ito, K. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1451056 · Cited by 17
Identification of a Proteomic Signature of Senescence in Primary Human Mammary Epithelial Cells
Delfarah, A., Hartel, N. G., Zheng, D., Yang, J., & Graham, N. A. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00659 · Cited by 8
Gu, J. (2025) · American Journal of Cancer Research · doi:10.62347/atcd4291 · Cited by 11
Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment
Pukhalskaia, T. V., Yurakova, T. R., Bogdanova, D. A., & Demidov, O. N. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050055 · Cited by 15
“Removal of the p16 INK4a+ senescent Cardiac glycosides mainly inhibitors of Na + /K + -ATPase not investigated [93-95] cells using senolytic approaches was shown to pro-long survival and inhibit tumor growth [8, 83].”
MethodPorika, M., Tippani, R., & Saretzki, G. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063002 · Cited by 17
The impact of aging on cardiac repair and regeneration
Anwar, I., Wang, X., Pratt, R. E., Dzau, V. J., & Hodgkinson, C. P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107682 · Cited by 12
“These cells accumulate in the heart where they promote organ dysfunction and decreased lifespan (77).”
Background[Translated article] Oral Supplementation and Systemic Drugs for Skin Aging: A Narrative Review
Morgado‐Carrasco, D., Gil‐Lianes, J., Jourdain, E., & Piquero‐Casals, J. (2022) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2022.09.021 · Cited by 19
Lemaître, J.-M. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19820 · Cited by 14
“31 Indeed, when the INK-ATTAC transgene was used to induce apoptosis in p16-expressing senescent cells in non-progeroid transgenic mice by injection of the same inducing drug, the median lifespan of the treated mice was extended by about 30%, tumorigenesis was delayed and age-related organ…”
MethodThe Discovery of Druggable Anti-aging Agents
Yalcin, G., & Lee, C. (2020) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.20.0092 · Cited by 12
Senescent cells in tissue engineering
Chin, A. F., & Elisseeff, J. H. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102737 · Cited by 13
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity
Su, Z., Su, H., Xu, J., Wei, G., Qu, L., Ni, T., Yang, D., & Zhu, Y. Z. (2022) · Aging · doi:10.18632/aging.204449 · Cited by 11
Rey‐Millet, M., Pousse, M., Soithong, C., Ye, J., Méndez-Bermúdez, A., & Gilson, É. (2023) · Aging Cell · doi:10.1111/acel.13804 · Cited by 11
“Among them, the accumulation of senescent cells appears as a major contributor to physiological and pathological aging (Anderson et al., 2019; Baker et al., 2011, 2016).”
BackgroundHarada, M., Su-Harada, K., Kimura, T., Ono, K., & Ashida, N. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2325802 · Cited by 11
Chiche, A., Djoual, L., Charifou, E., Wang, S., Temime, L., Saclier, M., Wang, S., Chantrel, J., & Li, H. (2026) · Nature Aging · doi:10.1038/s43587-025-01058-y · Cited by 12
“2c,d), consistent with developmental senescence 16 .”
Kwon, H. J., Hahn, K. R., Nam, S. M., Yoon, Y. S., Moon, S. M., Hwang, I. K., & Kim, D. W. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105552 · Cited by 12
Zumerle, S., & Alimonti, A. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0540-x · Cited by 11
Cellular Transformation by Human Cytomegalovirus
Herbein, G. (2024) · Cancers · doi:10.3390/cancers16111970 · Cited by 15
“…of a senescence-associated secretory phenotype (SASP) with the release of cytokines, chemokines and proteases [135–137], and transitory and reversible senescent cell states whereby senescent cancer cells can escape senescence and resume cell proliferation and acquire oncogenic traits [138,139].”
BackgroundInvolvement of astrocyte senescence in Alzheimer's disease
Tüzer, F., & Torres, C. A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102594 · Cited by 13
Al‐Naggar, I. M., Antony, M. B., Baker, D. S., Wang, L., Godoy, L. D. C., Kuo, C., Fraser, M. O., Smith, P. P., Xu, M., & Kuchel, G. A. (2024) · Aging Cell · doi:10.1111/acel.14399 · Cited by 12
“Animal studies investigating biologic aging pathways demonstrate the importance of senescent cells in age-associated physiologic dysfunction (Baker et al., 2016 ; Suryadevara et al., 2024 ; Wang et al., 2021 ).”
Self-citationAging microvasculature: Effects on immune cell trafficking and inflammatory diseases
Reglero-Real, N., Rolas, L., & Nourshargh, S. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20242154 · Cited by 14
Modelling the ageing dependence of cancer evolutionary trajectories
Henry, C. J., & DeGregori, J. V. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00838-3 · Cited by 15
“These mouse models have been used to show how eliminating senescent cells can decrease ageing-dependent tumorigenesis (and other ageing phenotypes) 143 , how senescence contributes to chemotherapy-induced side effects 144 , that clearance of senescent cells can alleviate lung airspace enlargement…”
Ethical perspectives on advances in biogerontology
Woo, J., Archard, D., Au, D. K.-S., Bergstresser, S. M., Erler, A., Kwok, T. C. Y., Newman, J., Tong, R. K., & Walker, T. W. M. (2019) · Aging Medicine · doi:10.1002/agm2.12061 · Cited by 13
Senescent cells in the development of cardiometabolic disease
Postmus, A. C., Sturmlechner, I., Jonker, J. W., van Deursen, J. M., van de Sluis, B., & Kruit, J. K. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000602 · Cited by 10
Self-citationSystematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
Lewis, C. J., & de Grey, A. D. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2330425 · Cited by 10
“The choice to include a senolytic in combination studies was similarly straightforward – the field has grown exponentially in recent years following the unexpectedly wide-ranging effects of senescent cell ablation reported in early studies [6,45,46].”
Fibroblast senescence-associated extracellular matrix promotes heterogeneous lung niche
Howes, A. M., Dea, N. C., Ghosh, D., Krishna, K., Wang, Y., Li, Y., Morrison, B., Toussaint, K. C., & Dawson, M. (2024) · APL Bioengineering · doi:10.1063/5.0204393 · Cited by 17
Dual Activity of Type III PI3K Kinase Vps34 is Critical for NK Cell Development and Senescence
Chen, S., Li, Z., Jin, F., Quan, Y., He, J., Hao, J., & Dong, Z. (2024) · Advanced Science · doi:10.1002/advs.202309315 · Cited by 13
Reindl, J., Abrantes, A. M., Ahire, V. R., Azimzadeh, O., Baatout, S., Baeyens, A., Baselet, B., Chauhan, V., Pieve, F. D., Delbart, W., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-18810-7_3 · Cited by 28
Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury
Nishimura, K., Taguchi, K., Kishi, S., Brooks, C. R., Ochi, A., Kadoya, H., Ikeda, Y., Miyoshi, M., Tamaki, M., Abe, H., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.111 · Cited by 10
Phosphoproteome profiling of mouse liver during normal aging
Liu, J.-F., Wu, Y., Yang, Y.-H., Wu, S., Liu, S., Xu, P., & Yang, J. (2022) · Proteome Science · doi:10.1186/s12953-022-00194-2 · Cited by 13
Feng, J., Xu, H.-Q., Pan, F., Hu, J., Wu, Y., Lin, N., Zhang, X., Ji, C., Hu, Y., Zhong, H., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00046 · Cited by 10
Targeting immunosenesence promotes clearance of senescent cells
Tizazu, A. M., Tessema, E. A., & Cexus, O. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00518-8 · Cited by 15
“Still, the increased accumulation of senescent cells with age indicates the failure of the immune system to clear these cells [16, 58], especially as immunosenescence affects all arms of the immune system.”
InfluentialZhang, K., Wang, X., Zhang, Y., Li, Y., Wu, Y., Nuerlan, G., Li, Q., Mao, J., Gong, S., & Liu, Y. (2025) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.70031 · Cited by 15
Lozano‐Torres, B., Blandez, J. F., García‐Fernández, A., Sancenón, F., & Martínez‐Máñez, R. (2022) · FEBS Journal · doi:10.1111/febs.16477 · Cited by 9
Novel anti-aging gene NM_026333 contributes to proton-induced aging via NCX1-pathway
Osanai, T., Tanaka, Μ., Mikami, K., Kitajima, M., Tomisawa, T., Magota, K., Tomita, H., & Okumura, K. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.10.021 · Cited by 10
Cholesterol Accumulation Promotes Photoreceptor Senescence and Retinal Degeneration
Terao, R., Sohn, B. S., Yamamoto, T., Lee, T. J., Colasanti, J. J., Pfeifer, C. W., Lin, J. B., Santeford, A. C., Yamaguchi, S., Yoshida, M., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.10.29 · Cited by 11
Partial recovery of senescence in circulating follicular helper T cells after Dasatinib treatment
Talepoor, A. G., Khosropanah, S., & Doroudchi, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107465 · Cited by 10
Inhibition of ‘jumping genes’ promotes healthy ageing
Childs, B. G., & van Deursen, J. (2019) · Nature · doi:10.1038/d41586-018-07553-0 · Cited by 11
Self-citationSenolytic CAR T cells reverse aging-associated defects in intestinal regeneration and fitnessPreprint
Eskiocak, O., Chowdhury, S., Shah, V., Nnuji-John, E., Chung, C., Boyer, J. A., Harris, A. S., Habel, J., Sadelain, M., Beyaz, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.19.585779 · Cited by 11
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy
Jiménez-Castilla, L., Marín‐Royo, G., Orejudo, M., Opazo-Ríos, L., Caro-Ordieres, T., Artaiz, I., Suarez-Cortes, T. M., Zazpe, A., Hernández, G., Gómez‐Guerrero, C., et al. (2021) · Antioxidants · doi:10.3390/antiox10121920 · Cited by 11
Georgakopoulou, E. A., Valsamidi, C., Veroutis, D., & Havaki, S. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111409 · Cited by 13
Manavi, Z., Melchor, G. S., Bullard, M. R., Gross, P. S., Ray, S., Gaur, P., Baydyuk, M., & Huang, J. K. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03425-3 · Cited by 10
“Cellular senescence is a stress-induced irreversible cell-cycle arrest response triggered by advanced age [7] or chronic inflammation and observed in many neurodegenerative diseases [8–14].”
Morgado‐Carrasco, D., Gil‐Lianes, J., Jourdain, E., & Piquero‐Casals, J. (2022) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2022.09.014 · Cited by 22
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process
Majumder, A., Bano, S., & Nayak, K. B. (2024) · Biomolecules · doi:10.3390/biom14111387 · Cited by 14
Shaving black fur uncovers hidden issues in p16-3MR micePreprint
Hori, N., Kawamoto, S., Uemura, K., Okumura, Y., Tanaka, K., Park, J. H., Ohtani, N., Motooka, D., & Hara, E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.24.600181 · Cited by 10
Robbins, P. D., & Niedernhofer, L. J. (2017) · Aging Cell · doi:10.1111/acel.12620 · Cited by 12
S-Adenosylmethionine Metabolism and Aging
Loenen, W. A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811060-7.00003-6 · Cited by 15
CCL11 (Eotaxin) Promotes the Advancement of Aging-Related Cardiovascular Diseases
Zhang, T., Huang, Y., Ji, X., Wu, T., & Xiao, P. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm26020 · Cited by 11
Autophagy: ‘Self-Eating’ Your Way to Longevity
Pattison, C. J., & Korolchuk, V. I. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_2 · Cited by 11
Effects of CREG1 on Age-Associated Metabolic Phenotypes and Renal Senescence in Mice
Hashimoto, M., Goto, A., Endo, Y., Sugimoto, M., Ueda, J., & Yamashita, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031276 · Cited by 10
Cellular senescence in kidney diseases
Wang, X., Li, Y., Chu, Q., Lv, H., Li, J., & Yi, F. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003746 · Cited by 13
“[14] p16 is also involved in the immune surveillance evasion of senescent cells.”
Bmi-1 determines the stemness of renal stem or progenitor cells
Zhou, J., Chen, A., Wang, Z., Zhang, J., Chen, H., Zhang, H., Wang, R., Miao, D., & Jin, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.140 · Cited by 9
Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons
Zhong, D., Sun, Y., Zhao, L., Hu, Z., Li, G., Li, H., & Xie, Z. (2025) · Medical Review · doi:10.1515/mr-2025-0047 · Cited by 20
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.